Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 6.

Vollbrecht, C., Koenig, K., Heukamp, L. C., Peifer, M., Buettner, R., Odenthal, M. and Schweighofer, C. D. (2014). Detection of hot spot and pathway related variants in chronic lymphocytic leukemia by multiplexed amplicon sequencing. Eur. J. Cancer, 50. S. S145 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Vollbrecht, C., Koitzsch, U., Koenig, K., Kloth, M., Buettner, R. and Odenthal, M. (2014). Process-automation of next generation sequencing for high-throughput mutation analyses in cancer. Eur. J. Cancer, 50. S. S93 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Vollbrecht, C., Mairinger, F. D., Koitzsch, U., Peifer, M., Koenig, K., Heukamp, L., Crispatzu, G., Wilden, L., Kreuzer, K-A, Hallek, M., Odenthal, M., Herling, C. D. and Buettner, R. (2016). Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing. Oncol. Res. Treat., 39. S. 159 - 160. BASEL: KARGER. ISSN 2296-5262

Vollbrecht, C., Mairinger, F. D., Schweighofer, C. D., Heukamp, L. C., Merkelbach-Bruse, S., Buettner, R. and Odenthal, M. (2014). Testing cancer related gene panels for high throughput parallel sequencing. Eur. J. Cancer, 50. S. S145 - 2. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Walter, R. F. H., Mairinger, F. D., Ting, S., Vollbrecht, C., Mairinger, T., Theegarten, D., Christoph, D. C., Schmid, K. W. and Wohlschlaeger, J. (2015). MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53. Br. J. Cancer, 112 (5). S. 883 - 891. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827

Walter, R. F. H., Mairinger, F. D., Ting, S., Vollbrecht, C., Mairinger, T., Theegarten, D., Christoph, D. C., Schmid, K. W. and Wohlschlaeger, J. (2015). MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53. Br. J. Cancer, 112 (5). S. 883 - 891. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827

This list was generated on Wed Dec 8 04:18:43 2021 CET.